Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1084
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity ; day:10 ; month:9 ; year:2020 ; pages:1-9
European radiology ; (10.9.2020), 1-9
- Urheber
-
Runge, Jurgen H.
Giessen, Jet van
Draijer, Laura G.
Deurloo, Eline E.
Smets, Anne M. J. B.
Benninga, Marc A.
Koot, Bart G. P.
Stoker, Jaap
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00330-020-07245-2
- URN
-
urn:nbn:de:101:1-2020103021525413346588
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Runge, Jurgen H.
- Giessen, Jet van
- Draijer, Laura G.
- Deurloo, Eline E.
- Smets, Anne M. J. B.
- Benninga, Marc A.
- Koot, Bart G. P.
- Stoker, Jaap
- SpringerLink (Online service)
Ähnliche Objekte (12)
Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
Hepatic steatosis in women with polycystic ovary syndrome
Xanthine oxidoreductase activity is correlated with hepatic steatosis
Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy
Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population
Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard
Attenuation of hepatic steatosis and insulin resistance by group VIA phospholipase A2 deficiency in Ob/Ob mice
Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
Inhibition of uncoupling protein 2 with genipin exacerbates palmitate-induced hepatic steatosis
The association of hepatic steatosis and fibrosis with heart failure and mortality
Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
Hepatic steatosis in women with polycystic ovary syndrome
Xanthine oxidoreductase activity is correlated with hepatic steatosis
Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy
Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population
Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard
Attenuation of hepatic steatosis and insulin resistance by group VIA phospholipase A2 deficiency in Ob/Ob mice
Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
Inhibition of uncoupling protein 2 with genipin exacerbates palmitate-induced hepatic steatosis
The association of hepatic steatosis and fibrosis with heart failure and mortality
Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
Hepatic steatosis in women with polycystic ovary syndrome
Xanthine oxidoreductase activity is correlated with hepatic steatosis
Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy
Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population
Supaglutide alleviates hepatic steatosis in monkeys with spontaneous MASH
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard
Attenuation of hepatic steatosis and insulin resistance by group VIA phospholipase A2 deficiency in Ob/Ob mice
Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
Inhibition of uncoupling protein 2 with genipin exacerbates palmitate-induced hepatic steatosis